Literature DB >> 10979655

Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole.

A Reis, R Sundmacher, K Tintelnot, H Agostini, H E Jensen, C Althaus.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10979655      PMCID: PMC1723572          DOI: 10.1136/bjo.84.8.928d

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  24 in total

1.  In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results.

Authors:  Niki I Paphitou; Luis Ostrosky-Zeichner; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

2.  Histological examination of an eye with endogenous Aspergillus endophthalmitis treated with oral voriconazole: a case report.

Authors:  Shakhsanam E Aliyeva; Andrew J Ullmann; Ulrike B Kottler; Martine Frising; Oliver Schwenn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-03-30       Impact factor: 3.117

3.  Scedosporium apiospermum traumatic endophthalmitis successfully treated with voriconazole.

Authors:  Andrea Zarkovic; Stephen Guest
Journal:  Int Ophthalmol       Date:  2007-09-28       Impact factor: 2.031

4.  The use of voriconazole in the treatment of Aspergillus fumigatus keratitis.

Authors:  Rosalind M K Stewart; Say Aun Quah; Timothy J Neal; Stephen B Kaye
Journal:  Br J Ophthalmol       Date:  2007-08       Impact factor: 4.638

Review 5.  Corneal ulceration in pediatric patients: a brief overview of progress in topical treatment.

Authors:  Serina Stretton; Usha Gopinathan; Mark D P Willcox
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

6.  Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.

Authors:  Michael A Thiel; Annelies S Zinkernagel; Jürgen Burhenne; Claude Kaufmann; Walter E Haefeli
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

Review 7.  Current perspectives on ophthalmic mycoses.

Authors:  Philip A Thomas
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

8.  Safety of intravitreal voriconazole: electroretinographic and histopathologic studies.

Authors:  Hua Gao; Mark Pennesi; Kekul Shah; Xiaoxi Qiao; Seenu M Hariprasad; William F Mieler; Samuel M Wu; Eric R Holz
Journal:  Trans Am Ophthalmol Soc       Date:  2003

9.  Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis.

Authors:  Daoud Al-Badriyeh; Chin Fen Neoh; Kay Stewart; David C M Kong
Journal:  Clin Ophthalmol       Date:  2010-05-06

Review 10.  Pediatric Clinical Pharmacology of Voriconazole: Role of Pharmacokinetic/Pharmacodynamic Modeling in Pharmacotherapy.

Authors:  Rajendra S Kadam; Johannes N Van Den Anker
Journal:  Clin Pharmacokinet       Date:  2016-09       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.